Biotronik Wants $100M Suit Over J&J Stent Recall Reopened

Law360, New York (March 27, 2012, 7:15 PM EDT) -- German drugmaker Biotronik AG asked a New York state appeals court Tuesday to allow it to seek $100 million in lost profits after a Johnson & Johnson unit's stent recall, arguing that profits were an integral part of its distribution contract with the company.

J&J unit Conor Medsystems Inc. allegedly cost Biotronik $100 million in lost profits after it breached their supply contract with a bogus recall of CoStar stents it made. Profits were built into that supply contract with provisions about markups and gross profits,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.